|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,528 JPY | +0.13% |
|
+3.50% | -0.09% |
| 2023 | Harris Associates says cautious on Japan, all in on Europe | RE |
| 2023 | Consolidation to boost value of Japan's still fragmented drugstore sector - Orbis | RE |
Sundrug Co.,Ltd. reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was JPY 690,462 million. Net income was JPY 25,703 million.
Basic earnings per share from continuing operations was JPY 219.83. Diluted earnings per share from continuing operations was JPY 219.82.
| 1st Jan change | Capi. | |
|---|---|---|
| -0.09% | 3.36B | |
| -11.64% | 3.62B | |
| -23.44% | 3.06B | |
| +7.46% | 2.59B | |
| -9.26% | 1.75B | |
| +9.30% | 1.35B | |
| -20.60% | 957M | |
| -38.42% | 704M | |
| -0.53% | 450M | |
| -1.85% | 370M |
SUNDRUG CO.,LTD. 
